Cargando…
MiTF is Associated with Chemoresistance to Cisplatin in A549 Lung Cancer Cells via Modulating Lysosomal Biogenesis and Autophagy
BACKGROUND: Non-small cell lung carcinoma (NSCLC) is often fatal; advanced NSCLC has a 5-year survival rate less than 20%. Platinum-based chemotherapy, in particular, cis-diamminedichloroplatinum (II) (cisplatin or DDP), is employed for the treatment of NSCLC; however, the drug resistance occurs fre...
Autores principales: | Li, Wei, Qin, Xia, Wang, Bin, Xu, Ge, Zhang, Jun, Jiang, Xuejun, Chen, Chengzhi, Qiu, Feng, Zou, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398682/ https://www.ncbi.nlm.nih.gov/pubmed/32801894 http://dx.doi.org/10.2147/CMAR.S255939 |
Ejemplares similares
-
The underestimated role of the microphthalmia-associated transcription factor (MiTF) in normal and pathological haematopoiesis
por: Oppezzo, Alessia, et al.
Publicado: (2021) -
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022) -
FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells
por: Bourseguin, Julie, et al.
Publicado: (2016) -
The Regulation of MiTF/TFE Transcription Factors Across Model Organisms: from Brain Physiology to Implication for Neurodegeneration
por: Agostini, Francesco, et al.
Publicado: (2022) -
MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat
por: Annunziata, Ida, et al.
Publicado: (2019)